¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"bone phosphate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • carpal bone
    ¼Õ¸ñ»À, ¼ö±Ù°ñ
  • cartilage bone
    ¿¬°ñ»À
  • cancellous bone
    °¹¼Ø»À, ÇØ¸é°ñ
  • endochondral bone
    ¿¬°ñ³»»À
  • ethmoid bone
    ¹úÁý»À, »ç°ñ
  • fibrous dysplasia of bone
    »À¼¶À¯Çü¼ºÀÌ»ó
  • flat bone
    ³³ÀÛ»À, ÆíÆò°ñ
  • frontal bone
    À̸¶»À, ÀüµÎ°ñ
  • heel bone
    ¹ß²ÞÄ¡»À, Á¾°ñ
  • herring bone appearance
    û¾î»À¸ð¾ç
  • herring bone artifact
    û¾î»ÀÇã»ó, û¾î»ÀÀΰø¹°
  • hamate bone
    °¥°í¸®»À
  • hammer bone
    ¸ÁÄ¡»À
  • hip bone
    º¼±â»À, °ü°ñ
  • hyoid bone
    ¸ñ»Ô»À, ¼³°ñ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • compact bone
    Ä¡¹Ð»À
  • cortical bone
    °ÑÁú»À
  • costal bone
    (¢¡rib) °¥ºñ»À, ´Á°ñ
  • cranial bone
    ¸Ó¸®»À, µÎ°³°ñ
  • cuboid bone
    ÀÔ¹æ»À
  • cuneiform bone
    ½û±â»À
  • ethmoid bone
    ¹úÁý»À, »ç°ñ
  • flat bone
    ³³ÀÛ»À
  • frontal bone
    À̸¶»À
  • hamate bone
    °¥°í¸®»À
  • hammer bone
    (¢¡malleus) ¸ÁÄ¡»À
  • heel bone
    (¢¡calcaneus) ¹ß²ÞÄ¡»À
  • hip bone
    º¼±â»À, °ü°ñ
  • hyoid bone
    ¸ñ»Ô»À
  • innominate bone
    (¢¡hip bone) º¼±â»À, °ü°ñ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • hip bone
    °ü°ñ(ΰÍé).
  • hip bone
    º¼±â»À °ü°ñ
  • hip bone
    °ü°ñ(ΰÍé), µÐ°ñ(ÔëÍé), °í°ñ(ÍÆÍé), °ñ¹Ý°ñ(ÍéÚïÍé), ¹«¸í°ñ(ÙíÙ£Íé), ¾ûÄ¡»À.
  • horn of hyoid bone
    ¼³°ñ»Ô, »ó°¢(ß¾ÊÇ).
  • hyoid bone
    ¼³°ñ.
  • hyoid bone
    ¸ñ»Ô»À ¼³°ñ
  • hyoid bone
    ¼³°ñ
  • iliac bone <³ª> os ilium
    Àå°ñ(Àå°ñ).
  • iliac bone ³ª os ilium
    Àå°ñ(íóÍé).
  • immature compact bone
    ¹Ì¼º¼÷Ä¡¹Ð»À
  • incisive bone
    (¾Õ´Ï»À)
  • incisive bone premaxilla ; os incisivum ³ª
    ¾Õ´Ï°ñ, ÀýÄ¡°ñ(ôîöÍÍé).
  • inferior body of hyoid bone
    ¸ñ»Ô»À¾Æ·¡¸öÅë
  • inlay bone graft
    ³»Àç °ñ À̽Ä(Ò®î¤Íéì¹ãÕ), °¨ÀÔ °ñ À̽Ä(ÊîìýÍéì¹ãÕ).
  • innominate bone ³ª os coxae
    °ü°ñ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • alveolar bone
    ÀÌÆ²»À
  • articular surface for cuboid bone
    ÀÔ¹æ°üÀý¸é
  • articular surface for navicular bone
    ¹ß¹è°üÀý¸é
  • aseptic bone necrosis
    ¹«±Õ¼º °ñ ±«»ç(ÙíжàõÍéÎÕÞÝ).
  • astragaloscaphoid bone
    °Å°ñ ÁÖ»ó°ñ(¡­ñÇßÒÍé).
  • audiometry, bone conduction
    °ñµµÃ»·Â û°¢°Ë»ç
  • autogenous bone graft
    ÀÚ°¡°ñ À̽Ä(¼ú)(í»Ê«Íéì¹ãÖâú).
  • autologous bone marrow transplantation
    ÀÚ°¡°ñ¼öÀ̽Ä(¡­ÍéâÐì¹ãÕ).
  • base of metatarsal bone
    ¹ßÇ㸮»À¹Ù´Ú
  • blade bone
    °ß°© °ñ(Ì·Ë£Íé), Ä®³¯ »À, ³¯°³ »À.
  • blade bone
    °ß°©°ñ(Ì·Ë£Íé).
  • body of hyoid bone
    ¼³°ñ¸öÅë, ¼³°ñü(àßÍéô÷).
  • body of hyoid bone
    ¸ñ»Ô»À¸öÅë
  • body of metatarsal bone
    ¹ßÇ㸮»À¸öÅë
  • body shaft of metacarpal bone ; corpus ossis metacarpalis
    Á¤¿Ü Áß¼ö°ñü.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Secondary bone
    ÀÌÂ÷»À
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñ
  • Secondary bone trabecula
    ÀÌÂ÷»ÀÀܱâµÕ
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñ¼ÒÁÖ
  • Secondary sponge bone
    ÀÌÂ÷ÇØ¸é»À
    [¿¾ ¿ë¾î] ÀÌÂ÷ÇØ¸é°ñ
  • Alveolar bone
    ÀÌÆ²»À
    [¿¾ ¿ë¾î] Ä¡Á¶°ñ
  • Primary bone
    ÀÏÂ÷»À
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ
  • Primary bone development
    ÀÏÂ÷»À¹ß»ý
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¹ß»ý
  • Primary bone trabecula
    ÀÏÂ÷»ÀÀܱâµÕ
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¼ÒÁÖ
  • Primary sponge bone
    ÀÏÂ÷ÇØ¸é»À
    [¿¾ ¿ë¾î] ÀÏÂ÷ÇØ¸é°ñ
  • Articular surface for cuboid bone
    ÀÔ¹æ°üÀý¸é
    [¿¾ ¿ë¾î] ÀÔ¹æ°ñ°üÀý¸é
  • Palatine bone
    ÀÔõÀå»À
    [¿¾ ¿ë¾î] ±¸°³°ñ
  • Palatine bone
    ÀÔõÀå»À [±¸°³°ñ]
    [¿¾ ¿ë¾î] ±¸°³°ñ
  • Trapezoid bone
    ÀÛÀº¸¶¸§»À
    [¿¾ ¿ë¾î] ¼Ò´ÉÇü°ñ
  • Red bone marrow
    Àû»ö°ñ¼ö [Àû»ö»À¼ÓÁú]
    [¿¾ ¿ë¾î] Àû°ñ¼ö
  • Red bone marrow
    Àû»ö°ñ¼ö [Àû»ö»À¼ÓÁú]
    [¿¾ ¿ë¾î] Àû»ö°ñ¼ö
  • Intermediate cuneiform bone
    Áß°£½û±â»À
    [¿¾ ¿ë¾î] Áß°£¼³»ó°ñ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
ABMT American Board of Medical Toxicology; autologous bone marrow transplantation
AC/BC air conduction/bone conduction [time ratio]
ADR activation, depression, repetition [in bone remodeling]; adrenodoxin reductase; Adriamycin; adverse ...
ANB avascular necrosis of bone
BA Bachelor of Arts; backache; bacterial agglutination; basilar artery; basion; benzyladenine; best amp...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
BMD Bone Mineral Density
BMP Bone Morphogenetic Protein
BMP-2 Bone Morphogenetic Protein 2
BMP-4 Bone Morphogenetic Protein 4
BMP1 Bone Morphogenetic Protein-1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bone marrow embolism
    °ñ¼ö »öÀüÁõ
  • bone marrow failure
    °ñ¼ö ±â´ÉºÎÁø
  • bone marrow needle
    °ñ¼ö õÀÚ Ä§
  • bone marrow puncture
    °ñ¼ö õÀÚ
  • bone marrow suppression
    °ñ¼ö ¾ïÁ¦
  • bone marrow-derived lymphocyte
    °ñ¼ö À¯·¡ Àӯı¸
  • bone maturation
    °ñ ¼ºÀå
  • bone meal
    »À°¡·ç, °ñºÐ
  • bone metastasis
    °ñ ÀüÀÌ
  • bone onlay
    °ñ ÀÌ½ÄÆí
  • bone peg
    »À¸ø, °ñÁ¤
  • bone proliferation
    °ñ Áõ½Ä
  • bone reduction procedure
    °ñ Á¦°Å¼ú
  • bone remodeling
    °ñ ÀçÇü¼º
  • bone repair
    °ñ ȸº¹
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
glycerol-3-phosphate dehydrogenase Alpha-Glycerol phosphate dehydrogenase; 3-phosphoglycerol dehydrogenase;an oxidoreductase that catalyses the interconversion of dihydroxyacetone phosphate and sn-glycerol 3-phosphate, with the participation of NAD+; its action provides the glycerol moiety from carbohydrate during lipogenesis.
(05 Mar 2000)
glycerol-3-phosphate - glucose phosphotransferase <enzyme> Catalyses the formation of glycerol and glucose-6-phosphate
Registry number: EC 2.7.1.142
Synonym: gro3p-glucose transphorylase, glycerol 3-phosphate-glucose transphorylase
(26 Jun 1999)
glycerol-3-phosphate o-acyltransferase <enzyme> An enzyme that transfers acyl groups from acyl-CoA to glycerol-3-phosphate to form monoglyceride phosphates. It acts only with CoA derivatives of fatty acids of chain length above c-10. Also forms diglyceride phosphates.
Chemical name: Acyl-CoA:sn-glycerol-3-phosphate 1-O-acyltransferase
Registry number: EC 2.3.1.15
(12 Dec 1998)
glycerol phosphate The anion of a phosphoric ester of glycerol; the 3-derivative is the central component of phosphatidates (R-glycerol 3-phosphate).
Synonym: glycerophosphate.
(05 Mar 2000)
pentose phosphate cycle <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate.
Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses.
In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection.
Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose.
(18 Nov 1997)
pentose phosphate pathway <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate.
Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses.
In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection.
Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose.
(18 Nov 1997)
retinyl phosphate The phosphoester of all-trans retinol; essential for the biosynthesis of certain glycoproteins needed for growth regulation and for mucous secretion.
(05 Mar 2000)
riboflavin 5'-phosphate <biochemistry> This biomolecule serves as a coenzyme for some enzymes that catalyse oxidation-reduction reactions.
(09 Oct 1997)
ribose-5-phosphate Ribose phosphorylated on carbon-5; an intermediate in the pentose phosphate pathway.
(05 Mar 2000)
ribose-5-phosphate isomerase <enzyme> An enzyme catalyzing interconversion of d-ribose 5-phosphate and d-ribulose 5-phosphate; of importance in ribose metabolism and in the pentose phosphate pathway.
Synonym: phosphopentose isomerase, phosphoriboisomerase.
(05 Mar 2000)
ribose-phosphate pyrophosphokinase <enzyme> An enzyme that catalyses the formation of phosphoribosyl pyrophosphate from ATP and ribose-5-phosphate.
Chemical name: ATP:ribose-5-phosphate pyrophosphotransferase
Registry number: EC 2.7.6.1
(12 Dec 1998)
guaiacol phosphate Phosphoric guaiacyl ether, a white crystalline powder, insoluble in water; used as an intestinal antiseptic and in fever.
(05 Mar 2000)
RNA 3'-terminal phosphate cyclase <enzyme> ATP dependent; forms 2',3' terminal cyclic phosphate on RNA which is then the substrate for RNA ligase of hela cells
Registry number: EC 6.5.-
Synonym: RNA tph cyclase
(26 Jun 1999)
choline-phosphate cytidylyltransferase <enzyme> An enzyme that catalyses the transfer of cytidylate (CMP) to choline phosphate to form CDPcholine. It is the rate-limiting enzyme in the choline pathway for the biosynthesis of phosphatidylcholine. Its activity is increased by glucocorticoids.
Registry number: EC 2.7.7.15
(12 Dec 1998)
chromic phosphate P 32 colloidal suspension A pure beta-emitting colloidal, nonabsorbable radiopharmaceutical administered into body cavities such as the pleural or peritoneal spaces to control malignant effusions.
See: sodium phosphate P 32.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á